SEC Form 4 · accession 0001019687-15-004032
Medytox Solutions, Inc. · MMMS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey L Wadman
Officer — Treasurer
Period of report
Nov 2, 2015
Accepted (ET)
Nov 12, 2015 · 2:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374536
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Common StockF1 | $4.00 | Nov 2, 2015 | D | 75,000 | D | Jun 30, 2015 | Jun 30, 2025 | Common Stock | 75,000 | 0 | D |
Explanation of responses
- F1The options were assumed by Rennova Health, Inc. ("Rennova") pursuant to the merger agreement among Medytox Solutions, Inc., CollabRx Merger Sub, Inc. and Rennova,